About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
HALO
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Halozyme Therapeutics Non-GAAP EPS of $0.82 misses by $0.01, revenue of $230.04M misses by $1.1M
- Halozyme Therapeutics Q4 2023 Earnings Preview
- J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma
- EU okays Takeda's Hyqvia co-formulated with Halozyme's Enhanze
- Lipocine licenses Tlando testosterone therapy to Verity Pharma
- Regeneron’s high-dose Eylea, argenx’s Vyvgart injectable among latest approvals in Japan
- Halozyme’s early 2023 results indicate a mixed performance
- Halozyme gains as U.S. and EU clear Enhanze-based products
- Top overweight stocks with high free cash flow and EPS growth - MS
- JNJ multiple myeloma therapy outperforms standard of care by 58%
- argenx slips as autoimmune disorder therapy fails in pivotal trial
- Teva gains U.S. approval for generic version of osteoporosis injection
- Argenx Vyvgart injectable granted EU nod for myasthenia gravis
- Halozyme Therapeutics Non-GAAP EPS of $0.75 beats by $0.04, revenue of $216M in-line
- Halozyme, Acumen enter collaboration for Alzheimer's drug candidate
- Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more
- Halozyme Therapeutics Q3 2023 Earnings Preview
- Bristol Myers succeeds in Phase 3 trial for subcutaneous Opdivo
- Roche granted U.K. approval for subcutaneous Tecentriq
- Halozyme Therapeutics Non-GAAP EPS of $0.74 beats by $0.10, revenue of $221.04M beats by $21.09M
PEERS
Date | Price | Open | High | Low | Vol | Change | |||
---|---|---|---|---|---|---|---|---|---|
Jan 29 | 55.83 | 56.03 |
56.74
|
55.12
|
841K | -0.3% | |||
Jan 28 | 56 | 55.97 |
56.82
|
55.66
|
1.2M | 0.25% | |||
Jan 27 | 55.86 | 55.69 |
57.25
|
55.24
|
914K | 0.16% | |||
Jan 24 | 55.77 | 55.29 |
56.08
|
54.97
|
732K | 0.25% | |||
Jan 23 | 55.63 | 55.22 |
55.87
|
54.96
|
935K | 0.63% | |||
Jan 22 | 55.28 | 55.79 |
56
|
54.99
|
1.2M | -1.18% | |||
Jan 21 | 55.94 | 55.1 |
56.39
|
54.88
|
1.2M | 2.08% | |||
Jan 17 | 54.8 | 55.66 |
55.73
|
54.76
|
942K | -1.03% | |||
Jan 16 | 55.37 | 54.64 |
55.79
|
54.64
|
1.6M | 1.58% | |||
Jan 15 | 54.51 | 54.39 |
55.3
|
54.05
|
2.0M | 1.26% | |||
Jan 14 | 53.83 | 54.74 |
54.87
|
53.26
|
1.4M | -0.57% | |||
Jan 13 | 54.14 | 52.65 |
54.84
|
52.23
|
2.0M | 2.54% | |||
Jan 10 | 52.8 | 53.95 |
53.99
|
52.66
|
2.1M | -1.79% | |||
Jan 8 | 53.76 | 54.12 |
55
|
51.91
|
2.7M | 5.02% | |||
Jan 7 | 51.19 | 51 |
51.73
|
50.35
|
1.8M | 1.35% | |||
Jan 6 | 50.51 | 47.75 |
50.81
|
47.75
|
1.9M | 5.80% | |||
Jan 3 | 47.74 | 48.2 |
48.53
|
47.52
|
993K | -0.56% | |||
Jan 2 | 48.01 | 48.23 |
49
|
47.86
|
1.2M | 0.42% | |||
Dec 31, 2024 | 47.81 | 48.2 |
48.72
|
47.72
|
843K | -0.38% | |||
Dec 30, 2024 | 47.99 | 48.65 |
48.8
|
47.65
|
892K | -0.29% | |||
Dec 27, 2024 | 48.13 | 47.6 |
48.26
|
47.56
|
946K | 0.21% | |||
Dec 26, 2024 | 48.03 | 47.47 |
48.24
|
46.99
|
762K | 1.03% | |||
Dec 24, 2024 | 47.54 | 47.25 |
47.63
|
46.76
|
309K | 0.81% | |||
Dec 23, 2024 | 47.16 | 46.77 |
47.34
|
46.26
|
1.5M | 0.43% | |||
Dec 20, 2024 | 46.96 | 47.03 |
48.21
|
46.88
|
4.8M | -0.76% | |||
Dec 19, 2024 | 47.32 | 46.94 |
48.11
|
46.9
|
1.8M | 1.02% | |||
Dec 18, 2024 | 46.84 | 48.66 |
49.6
|
46.45
|
1.9M | -3.62% | |||
Dec 17, 2024 | 48.6 | 47.58 |
48.82
|
47.54
|
1.3M | 1.19% | |||
Dec 16, 2024 | 48.03 | 48.1 |
48.88
|
47.69
|
2.2M | 0.06% | |||
Dec 13, 2024 | 48 | 47.32 |
48.31
|
47.31
|
932K | 0.36% | |||
Dec 12, 2024 | 47.83 | 47.39 |
48.64
|
47.39
|
928K | 0.93% | |||
Dec 11, 2024 | 47.39 | 49.24 |
49.35
|
47.08
|
1.2M | -3.4% | |||
Dec 10, 2024 | 49.06 | 49.26 |
49.79
|
48.32
|
1.1M | 0% | |||
Dec 9, 2024 | 49.06 | 48.2 |
49.27
|
47.84
|
867K | 1.36% | |||
Dec 6, 2024 | 48.4 | 48.4 |
49.05
|
48.14
|
906K | 0.71% | |||
Dec 5, 2024 | 48.06 | 48.1 |
48.64
|
47.36
|
1.0M | -1.13% | |||
Dec 4, 2024 | 48.61 | 48.76 |
49.08
|
48.43
|
786K | 0.27% | |||
Dec 3, 2024 | 48.48 | 48.56 |
48.83
|
47.79
|
1.2M | -0.23% | |||
Dec 2, 2024 | 48.59 | 48.12 |
48.78
|
47.4
|
1.3M | 0.81% | |||
Nov 29, 2024 | 48.2 | 48.3 |
48.81
|
48.12
|
721K | -0.56% | |||
Nov 27, 2024 | 48.47 | 47.78 |
48.74
|
47.37
|
963K | 1.42% | |||
Nov 26, 2024 | 47.79 | 47.53 |
48.17
|
46.27
|
1.4M | 0% | |||
Nov 25, 2024 | 47.79 | 49.51 |
50
|
47.01
|
3.2M | -2.47% | |||
Nov 22, 2024 | 49 | 48.93 |
49.57
|
46.21
|
4.5M | 7.22% | |||
Nov 21, 2024 | 45.7 | 45.85 |
46.12
|
44.8
|
1.3M | -0.13% | |||
Nov 20, 2024 | 45.76 | 44.57 |
46.2
|
44.1
|
1.9M | 2.12% | |||
Nov 19, 2024 | 44.81 | 43.81 |
45.3
|
42.65
|
3.8M | 5.26% | |||
Nov 18, 2024 | 42.57 | 45.66 |
45.71
|
42.01
|
5.5M | -6.75% | |||
Nov 15, 2024 | 45.65 | 48.81 |
49.64
|
45.63
|
7.2M | -15.4% | |||
Nov 14, 2024 | 53.96 | 58.25 |
59.8
|
53.84
|
3.2M | -7.93% | |||
Nov 13, 2024 | 58.61 | 59.79 |
60.37
|
58.46
|
831K | -1.68% | |||
Nov 12, 2024 | 59.61 | 61.08 |
62.02
|
59.24
|
1.5M | -2.42% | |||
Nov 11, 2024 | 61.09 | 61.13 |
62.13
|
60.55
|
1.5M | 0.18% | |||
Nov 8, 2024 | 60.98 | 59.65 |
61.19
|
59.14
|
1.1M | 2.23% | |||
Nov 7, 2024 | 59.65 | 60.66 |
60.95
|
58.76
|
1.1M | -1.62% | |||
Nov 6, 2024 | 60.63 | 60.55 |
61.49
|
58.01
|
1.5M | 3.25% | |||
Nov 5, 2024 | 58.72 | 58 |
58.74
|
57.08
|
1.1M | 0.43% | |||
Nov 4, 2024 | 58.47 | 56.82 |
59.39
|
56.82
|
2.1M | 2.31% | |||
Nov 1, 2024 | 57.15 | 55.65 |
57.62
|
52.56
|
3.4M | 13.01% | |||
Oct 31, 2024 | 50.57 | 50.56 |
51.21
|
50.01
|
1.9M | 0% |